CBD Products & CBD Business News

Ex-US surgeon general joins CBD company’s advisory board

A former U.S. surgeon general is joining the advisory board of a California CBD company. Dr. Richard Carmona, who served as surgeon general from 2002 to 2008, will advise Kadenwood, a privately held company that makes topical CBD products in Newport Beach, California. The appointment gives Kadenwood a government insider to “shift the perception of […]

Read More

Hemp, CBD companies lining up university research to validate anecdotal evidence

A surge in academic research about hemp-derived cannabinoids is giving CBD companies new opportunities to find university partners to validate mountains of anecdotal evidence about cannabidiol’s health benefits. The research boom is enabled by hemp’s new legal status and funded by cannabis entrepreneurs who see an opportunity to bring a stamp of authority to an […]

Read More

Canadian acquisition underscores CBD’s potential in Europe

A Canadian marijuana producer cited hemp and CBD’s potential in Europe as it announced plans to acquire a smaller Canadian company with a CBD subsidiary in the Netherlands. The announcement Wednesday that Toronto-based Supreme Cannabis plans to acquire Truverra underscores the interest in accessing European markets. Supreme valued the acquisition at roughly $20 million. Supreme […]

Read More

Pictures, please! Hemp group wants more evidence to fight European CBD limit

European hemp producers and manufacturers are getting renewed pleas to help fight the European Union on how it treats CBD and other extracts. The European Industrial Hemp Association (EIHA) sent an alert this week to roughly 300 members urging the EU to change its Common Agricultural Policy, which governs food rules, according to Hemp Today. The […]

Read More

Here’s final chance to tell FDA how it should regulate CBD

U.S. health authorities are taking final comments from the public on how to regulate over-the-counter cannabis extracts such as CBD. The suggestions are due to the U.S. Food and Drug Administration (FDA) by midnight ET Tuesday, July 16, on how the agency should regulate cannabis-derived products. The FDA has vowed to expedite its review of cannabis-derived compounds […]

Read More

FDA to provide update on CBD review by late summer or fall, official says

Federal health regulators say they’ll update the hemp industry on their CBD review by late summer or fall. Dr. Amy Abernethy, who leads the U.S. Food and Drug Administration’s work group on cannabinoids such as CBD, said Friday the agency is “enthusiastic about research into the therapeutic benefits of CBD products but also need to balance […]

Read More

Investment firm increases stake in CBD company

Sol Global, a Toronto-based international cannabis investment firm, has increased its stake in a privately held CBD company. The firm announced Friday it spent 15 million Canadian dollars ($11.5 million) in HeavenlyRx. The purchase brings Sol Global to a 42% stake in HeavenlyRx. The announcement comes less than a week after Sol Global raised CA$50 […]

Read More

CBD company ups stake in beverage brand to secure 50-state distribution

A Toronto-based hemp and CBD investment company increased its stake in a traditional soda company with an eye toward developing CBD-infused beverages with the brand. HeavenlyRx bought 15 million shares in Jones Soda Co. for $9 million and now holds 39% of the Seattle-based beverage manufacturer. The deal also gives HeavenlyRx two seats on Jones Soda’s board. Jones […]

Read More

Demetrix raises $50 million to research synthetic cannabinoid production

California-based Demetrix secured $50 million in a Series A funding, which the company will use for research of synthetic cannabinoid production. The Emeryville company wants to use baker’s yeast to produce large volumes of cannabinoids. More than 100 of cannabinoids can be found in the cannabis plant, sometimes in trace amounts. The company did not […]

Read More

Hemptown acquires nutraceutical maker, moves into consumer packaged goods

Hemptown Organics Corp., a vertically integrated, multistate hemp producer based in Central Point, Oregon, has acquired longtime nutraceutical manufacturer Kirkman Group for $5 million. With $6 million in existing annual revenue, Kirkman operates a 25,000-square-foot nutraceutical manufacturing facility that is Current Good Manufacturing Process (CGMP)-certified and licensed by the U.S. Food and Drug Administration, according […]

Read More

Sol Global raises CA$50 million for CBD expansion; exec resigns

Sol Global, a Toronto-based international cannabis investment firm, said it raised 50 million Canadian dollars ($37.5 million) in debt financing. The company will use the proceeds to fund its expansion in CBD activities and operations in California, Florida and Michigan. The company also said Jonathan Gilbert resigned as president of its subsidiary, Impact Biosciences, which […]

Read More